Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.
Julieta RodriguezCapucine BaldiniArnauld BayleArnaud PagèsFrançois-Xavier DanlosDamien VasseurEtienne RouleauLudovic LacroixBeatriz Alonso de CastroVincent GoldschmidtLauren SeknaziAntoine HollebecqueJean Marie MichotStephane ChampiatAurélien MarabelleKaissa OualiChristophe MarzacSantiago PonceJean-Baptiste MicolNathalie ChaputChristophe MassardAntoine ItalianoPublished in: JCO precision oncology (2024)
. The presence of CHm had no impact on the population of patients treated in the phase I trials.